fda warning letters glp-1 compounding september 26 2025 warns against compounded medications FDA issued 25 warning letters

These pathways include the cyclic AMP-protein kinase A (cAMP-PKA) pathway, phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling, and nuclear factor kappa B (NF-B)-mediated cascades, which regulate cell proliferation, apoptosis, and migration

Treatment with JANUVIA at 100 mg daily provided significant improvements in A1C, FPG, and 2-hour PPG compared to placebo (Table 6)

When yeast infections occur during Zepbound treatment, they are more likely related to other risk factors rather than a direct medication effect

We monitor you to ensure safety

be sure to discuss your weight loss medication with us well in advance of your plastic surgery procedure with your surgeon to establish a safe timeline for discontinuing use